CCA
PAVM icon

Cruiser Capital Advisors’s PAVmed PAVM Stock Holding History

Cruiser Capital Advisors’s Portfolio PAVM Stock Details PAVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-156
Closed -$92K – 75
2022
Q1 		$92K Hold
156
– – 0.08% 55
2021
Q4 		$172K Hold
156
– – 0.12% 55
2021
Q3 		$598K Sell
156
-33
-17% -$104K 0.49% 29
2021
Q2 		$544K Hold
189
– – 0.46% 26
2021
Q1 		$377K Buy
+189
New +$284K 0.34% 29

Other funds holding PAVM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RA
RFG Advisory Birmingham, Alabama $6.4B AUM 19.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cruiser Capital Advisors's PAVM Position: Q2 2022 in Review

Cruiser Capital Advisors sold out of PAVmed (PAVM) in Q2 2022, closing a stake of 156 shares — an estimated $92K sold.

Cruiser Capital Advisors first reported a position in PAVM in Q1 2021 and held it in 5 quarters. The position peaked at $598K in Q3 2021. 73 funds tracked by Wall St. Rank hold PAVM as of Q2 2022.

  • Cruiser Capital Advisors reported no remaining PAVmed position as of Q2 2022 after selling out during the quarter.
  • Cruiser Capital Advisors sold 156 PAVmed shares in Q2 2022, an estimated $92K.
  • Cruiser Capital Advisors first reported a position in PAVmed in Q1 2021 and held it in 5 quarters.
  • Cruiser Capital Advisors's PAVmed position peaked at $598K in Q3 2021.
  • 73 funds tracked by Wall St. Rank held PAVmed as of Q2 2022.

Based on Cruiser Capital Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.